Combination fixed‐dose beta agonist and steroid inhaler as required for adults or children with mild asthma
<p><strong>Background</strong></p> <p>Asthma affects 350 million people worldwide including 45% to 70% with mild disease. Treatment is mainly with inhalers containing beta₂‐agonists, typically taken as required to relieve bronchospasm, and inhaled corticosteroids (ICS)...
| Hlavní autoři: | , , , , , , , , , |
|---|---|
| Médium: | Journal article |
| Jazyk: | English |
| Vydáno: |
Wiley
2021
|